GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actelion Ltd (XSWX:ATLNE) » Definitions » Price-to-Operating-Cash-Flow

Actelion (XSWX:ATLNE) Price-to-Operating-Cash-Flow : 7.93 (As of May. 02, 2024)


View and export this data going back to . Start your Free Trial

What is Actelion Price-to-Operating-Cash-Flow?

As of today (2024-05-02), Actelion's share price is CHF65.26. Actelion's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2017 was CHF8.23. Hence, Actelion's Price-to-Operating-Cash-Flow Ratio for today is 7.93.

The historical rank and industry rank for Actelion's Price-to-Operating-Cash-Flow or its related term are showing as below:

XSWX:ATLNE' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 8.44   Med: 20.47   Max: 137.53
Current: 31.64

During the past 13 years, Actelion's highest Price-to-Operating-Cash-Flow Ratio was 137.53. The lowest was 8.44. And the median was 20.47.

XSWX:ATLNE's Price-to-Operating-Cash-Flow is not ranked
in the Biotechnology industry.
Industry Median: 26.12 vs XSWX:ATLNE: 31.64

Actelion's Cash Flow from Operations per share for the three months ended in Mar. 2017 was CHF1.75. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2017 was CHF8.23.


Actelion Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Actelion's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actelion Price-to-Operating-Cash-Flow Chart

Actelion Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.99 14.69 83.67 23.80 25.84

Actelion Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.67 22.33 22.27 25.84 31.91

Competitive Comparison of Actelion's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Actelion's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Actelion's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Actelion's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Actelion's Price-to-Operating-Cash-Flow falls into.



Actelion Price-to-Operating-Cash-Flow Calculation

Actelion's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=65.26/8.225
=7.93

Actelion's Share Price of today is CHF65.26.
Actelion's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF8.23.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Actelion Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Actelion's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Actelion (XSWX:ATLNE) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Actelion is a Swiss biopharmaceutical firm with several products on the market, largely focused on pulmonary arterial hypertension: Tracleer, Opsumit, Uptravi, Ventavis, and Veletri treat various stages of the disease via different methods of administration. Zavesca is a second-line option for Gaucher disease, and Valchlor treats a rare form of blood cancer. Actelion has created a global commercial infrastructure for its approved orphan drugs and has supplemented its internal pipeline through in-licensing and acquisitions.

Actelion (XSWX:ATLNE) Headlines

No Headlines